The diagnostic capabilities of magnetic resonance imaging (MRI) have undergone continuous and substantial evolution by virtue of hardware and software innovations and the development and implementation of exogenous contrast media. Thirty years since the first MRI contrast agent was approved for clinical use, a reliance on MR contrast media persists, largely to improve image quality with higher contrast resolution and to provide additional functional characterization of normal and abnormal tissues. Further development of MR contrast media is an important component in the quest for continued augmentation of diagnostic capabilities. In this review we detail the many important considerations when pursuing the design and use of MR contrast media. We offer a perspective on the importance of chemical stability, particularly kinetic stability, and how this influences one's thinking about the safety of metal-ligand-based contrast agents. We discuss the mechanisms involved in MR relaxation in the context of probe design strategies. A brief description of currently available contrast agents is accompanied by an in-depth discussion that highlights promising MRI contrast agents in the development of future clinical and research applications. Our intention is to give a diverse audience an improved understanding of the factors involved in developing new types of safe and highly efficient MR contrast agents and, at the same time, provide an appreciation of the insights into physiology and disease that newer types of responsive agents can provide. I mage contrast in magnetic resonance (MR), the difference in signal intensity between tissues or anatomic spaces, can be enhanced or augmented by manipulation of imaging parameters and/or by the introduction of certain chemical (contrast) agents that influence the relaxation of water, the most abundant substance in human tissues. Such agents have proliferated because of their ability to facilitate detection and characterization of normal versus diseased tissues. Continued development of contrast agents (CA) is an important component of our efforts to increase the value proposition of MR technology. Such development entails considering a complex set of parameters, many of which interact with one another, often involving trade-offs among those parameters. The objective of this review is to summarize insights into lanthanide ion chemistry that will offer an appreciation for the challenges faced when trying to generate clinically safe, effective, and highly sensitive agents. Furthermore, it is intended that the reader also gains insight into the challenges and opportunities surrounding newer types of responsive MR agents that can provide additional physiological and biochemical information for diagnostic imaging. Given the diverse audience which will include readers that may not have a detailed chemistry background or familiarity with the relevant nomenclature, certain words have been included in a Glossary section that describes the words and related concepts.
Current MRI Contrast Agents
MRI CAs have been widely used in diagnostic imaging for nearly 30 years. Most current CAs are either simple paramagnetic metal ion-ligand (ML) complexes or superparamagnetic particles, both of which alter image contrast by decreasing the T 1 and T 2 of water protons. The first paramagnetic complex approved in 1987 for use in cancer patients to detect brain tumors was gadolinium(III) diethylenetetraamine pentaacetic acid (GdDTPA). This first approval stimulated intense worldwide interest in understanding the precise physical-chemical mechanisms by which these agents work in vivo. This in turn led to new chemical insights into how to maximize the sensitivity of such agents and, more important, how to create responsive or smart agents that can potentially provide added biochemical or physiological information to aid in a clinical diagnosis.
T 1 -Based CAs T 1 -based contrast agents are exogenous paramagnetic metal ion complexes that shorten the longitudinal relaxation time of surrounding water protons. These are also referred to as "positive" agents because they typically produce image brightening in T 1 -weighted imaging sequences. The gadolinium ion (Gd 31 ) which lies in the middle of the lanthanide (Ln) family of elements is the metal of choice for nearly all T 1 -based agents because it has seven unpaired electrons in its 4f orbitals, a high magnetic moment (l 2 5 63 BM 2 ), and an unusually long electronic spin relaxation time. 1, 2 This makes relaxation of any nearby water protons efficient on a per mole basis. The "free" or unchelated Gd 31 ion is toxic in most biological systems largely because the ion has an ionic radius close to that of Ca 21 From a safety perspective, the resulting ML complexes must be thermodynamically stable (Table 1) and, more important for in vivo use, kinetically inert. The thermodynamic stability of a Gd 31 complex, defined by the equilibrium constant, K st , is a measure of how much free, uncomplexed Gd 31 ion will be released in a biological environment if the system reaches "equilibrium." The word "equilibrium" is emphasized here because these ML Table 1 are excreted long before any small amount of free Gd 31 can be released. This is why understanding the kinetics of complex dissociation is so important. The kinetic stability of any complex refers to how fast or slow a Gd 31 ion is released from an ML complex as reflected by the rate pseudo constant, k obs or proton assisted rate constant, k 1 (Table 1) .
To facilitate understanding of thermodynamic versus kinetic stability, we can consider an analogy with conversion of diamond to graphite. While this conversion is thermodynamically favorable because the free energy of graphite is lower than that of diamond, it does not readily occur under ordinary conditions because the kinetics of the reaction (requiring immense activation energy) is extremely slow. Thus, thermodynamic stability determines whether a given reaction is favorable (ie, spontaneous), but says nothing about the likelihood that the reaction will take place over a given period of time. If a reaction takes place extremely slowly compared to the amount of time an ML complex remains in the body, for example, then the reaction is considered kinetically inert. Unfortunately, the importance of kinetic inertness was not fully appreciated in the original design of MR contrast agents, so it was not until the emergence of nephrogenic systemic fibrosis (NSF) that the importance of kinetic stability was fully appreciated. It is now known that macrocyclic ligands have substantial advantages over linear polyaminobased ligands simply because the former are much more kinetically inert toward dissociation. 3, 5, 28, 29 
Here 1/T 1obs represents the observed water proton relaxation rate, 1/T 1d is the diamagnetic water proton relaxation rate, and 1/T 1p is the paramagnetic contribution. 1/T 1d is measured in the same conditions as 1/T 1obs but in the absence of the paramagnetic complex (solvent contribution). The relaxivity is composed of an inner sphere (IS) and an outer sphere (OS) term (Eq. [3] ). The inner sphere term describes the relaxation effect originating from the closest hydrogen nuclei of water molecules interacting directly with the paramagnetic ion, while the outer sphere term describes the effect of the interactions between the paramagnetic ion and closely diffusing water molecules without interacting with the complex (the outer sphere). In some cases, water molecules weakly interacting with the ligand might constitute a second hydration sphere, which can lead to a second sphere relaxivity term (Fig. 2) . For clinical agents, $60% of the relaxivity originates from inner sphere relaxation and 40% from outer sphere effects.
The inner sphere relaxivity term is linearly proportional to the hydration number (q) of the Gd 31 complex.
The agent structures shown in Fig. 1 (Fig. 2) .
T 2 -Based CAs T 2 CAs decrease the water signal intensity by shortening the transverse relaxation times. The large anisotropic magnetic susceptibility induced by these agents create local magnetic field gradients that efficiently dephase the transverse magnetization. The efficiency of a T 2 MR CA is defined by its relaxivity, r 2 , the transverse relaxation rate (r 2 5 1/T 2 ) observed for 1 mM solution of contrast media in water. Given the growth of higher magnetic field MRI scanners in clinical practice, T 2 contrast mechanisms due to endogenous and exogenous iron (iron oxide particles) have gained increased relevance. While studies have shown that the r 1 relaxivities of low molecular weight T 1 -based contrast agents are typically lower at high magnetic fields (B 0 ), the intrinsic T 1 of tissue water is also longer at higher fields, so the net efficiency of T 1 -based CA is not overly compromised, at least at field strengths that could become clinical over the next decade (up to 7T). Conversely, T 2 CAs can be an -complex (GdDOTA) with one coordinated water molecule (inner-sphere water, its oxygen is colored black) in solution (bulk water, oxygens are red). Second-sphere water molecules (water oxygens are blue) are close to the carboxylate groups with their hydrogens oriented towards the carboxylate oxygens. The parameters that govern the relaxivity are also represented: Gd-H distance, the mean lifetime (s m ) of the water molecule(s) in the inner sphere, the rotational correlation time (s R ) and the electronic spin relaxation times (T 1e and T 2e ). For clinical agents, $60% of the relaxivity originates from inner sphere relaxation and 40% from outer sphere effects. efficient solution for high field applications since the transverse relaxivity (r 2 ) increases at higher fields.
Currently, the majority of T 2 CAs are iron oxide-based superparamagnetic nanoparticles coated with dextran, silicates, or other nonimmunogenic polymers. Surface coating is useful not only for ensuring biocompatibility but also because most of the polymer coatings can be functionalized for selective targeting, multimodality, and therapy applications. [34] [35] [36] [37] In fact, depending on the coating identity and the size of iron-oxide particles, one can identify SPIO (superparamagnetic, 50-500 nm), USPIO (ultrasmall superparamagnetic, 4-50 nm), MION (monocrystalline), and CLIO (cross-linked) nanoparticles with quite variable T 2 relaxivities and tissue biodistribution. 38 The very favorable T 2 relaxivities of such nanoparticles makes them attractive for detecting specific biological targets by MRI but their large size can impede or alter tissue penetration and delivery, so untargeted SPIOs are the only nanoparticles used clinically to date. Outer-sphere theory for T 2 relaxivity predicts that the effectiveness of superparamagnetic particles is highly dependent on both the saturation magnetization (Ms) value and the effective radius (r) (Eq. [4] ).
where D is the diffusivity of water molecules, ' is the thickness of an impermeable surface coating, and k 5 V*/C where V* is the volume fraction and C is the total iron concentration. In a simplistic way, this equation tells us that increasing M s , reflected also as the ability of particles to easily be magnetized by the magnetic field, or the magnetic core radius will result in higher r 2 relaxivity. 41 Recently, many novel platforms, such as carbon nanotubes (iron oxidedoped), 42 zeolites (Dy 31 -doped), 43 and metal-organic frameworks (MOFS) (Dy 31 and Gd
31
-doped) 44, 45 have been studied as potential T 2 contrast agents. There is also growing interest in chemical exchange saturation transfer (CEST) and T 2 -exchange agents because small molecule agents, similar to the Gd 31 agents already in use clinically have some advantages over the larger nanoparticles. 46 It is important to note that all contrast agents shorten both T 1 and T 2 . It is the relative contribution to r 1 or r 2 that influence CA behavior. For iron agents, several factors contribute such as the crystalline symmetry, the size of the core, and the nature of the coating used for the core. 47, 48 For example, a ferumoxides injectable agent (Feridex) that had been used for liver imaging has a crystal aggregate structure with a dextran coating and its large size contributes to a large r 2 , which provides notable signal reduction when concentrated in the liver. On the other hand, Ferumoxtram (Sinerem), an iron oxide composed of smaller particles, has relatively less r 2 and more r 1 , characteristics that can facilitate magnetic resonance angiography (MRA) or other T 1 -weighted MR techniques. 49, 50 CEST AGENTS. This newest class of MR CAs is based on protons exchanging between one type of molecule and another. For example, if one dissolves a simple biomolecule such as an amino acid in water, the "exchangeable" -NH 2 and -CO 2 H protons exchange with water protons at some rate (carboxyl protons exchange fast, amino protons exchange more slowly). In tissue, there are obviously many different types of such exchangeable protons (every biomolecule that contains an -NH, -NH 2 , or -OH proton), each in exchange with water protons and each at a different rate. This phenomenon provides an opportunity to generate MRI contrast by a unique mechanism, as illustrated in Fig. 3A . In this example, protons in pool B (assume this represents a specific type of -NH 2 group on a protein) are exchanging with protons in pool A (water) at some slow rate. 51 The basic requirement for using this phenomenon as a method to produce MR contrast is that the chemical shift between the exchanging -NH 2 protons and bulk water (Dx) must be large enough to allow frequency-selective saturation of the -NH 2 resonance without also saturation of the water protons. If this requirement is met, then selective saturation of the -NH 2 protons for a period of time (typically 1-5 sec) results in a decrease in the intensity of the water signal (M z /M o ) because some of the saturated -NH 2 protons enter the pool of water protons during this saturation period. 52 The decrease in water intensity after reaching a new equilibrium is given by:
From an imaging perspective, the decrease in water intensity produced by CEST has the same net effect as a classical T 2 agent, i.e. the water intensity decreases and the image darkens. However, one great advantage of CEST over ironbased T 2 contrast agents is that the CEST signal can be turned "on" and "off" by the operator using the frequency-selective presaturation pulse. Consequently, the scientific interest in CEST, especially endogenous CEST contrast, is growing rapidly. 46, 52, 53 Two examples of the use of CEST imaging to detect some specific biological process are illustrated in Fig. 3 . The first example illustrates an endogenous CEST signal that arises after selective presaturation of all exchanging -NH protons. 53 The resulting change in water intensity (the CEST signal) is significantly higher in tumor than normal brain and, perhaps more important from a diagnostic viewpoint, this difference disappears after a single treatment with temozolomide (TMZ). The second example illustrates the use of an exogenous paraCEST agent as a glucose sensor. 54 One can see from Eq. [5] that CEST contrast (M z /M o ) depends on some of the same parameters as those governing T 1 -based agents including c, concentration, q (number of exchanging protons), the T 1 of bulk water protons, and s m , the water proton exchange lifetime. The basic rule that governs whether a molecule can act as a CEST contrast agent is that the chemical shift between the exchanging protons and water protons (Dx) must differ and the proton exchange rate must be slow compared to the frequency difference, Dx > k ex (or alternatively, DxÁs m > 1). Given that Dx increases with B 0 while k ex is independent of field strength, this also means that many more molecules (both endogenous and exogenous) should be amenable to CEST detection at higher imaging fields compared to lower imaging fields.
Methods to Optimize the r 1 scientists have focused on optimizing one of three parameters: q, s m , or s R . However, several parameters depend on the strength of magnetic field so this should be considered when designing a new CA.
MODULATING THE HYDRATION NUMBER, q. According to the Solomon-Bloembergen-Morgan (SBM) theory, proton relaxivity is directly proportional to the number of water molecules coordinated to the paramagnetic center. 25 This in principle means that one could simply increase the number of water molecules bound to Gd 31 and the r 1 relaxivity should increase proportionally. In the discussion that follows, we present perspectives largely based on our own experiences with GdDOTA, although the principles are broadly applicable to other nonmacrocyclic ligands as well. In aqueous media, GdDOTA exists as a mixture of two nonacoordinated isomers, a twisted square antiprism (TSAP), and a square antiprism (SAP), where Gd 31 sits in the center with An example of endogenous CEST in an orthotopic glioblastoma multiform (GBM) tumor in a mouse. Presaturation of all exchangeable amide protons at 3.5 ppm downfield of water results in a larger CEST signal in the tumor compared to the surrounding healthy brain. The bottom images illustrate that the CEST signal decreases after one round of temozolomide (TMZ) chemotherapy, the standard drug used in GBM patients. C: An example of an exogenous CEST agent. Here a Eu 31 macrocyclic ligand complex was designed to bind glucose. This glucose sensor shows no CEST signal in the absence of glucose but a strong CEST signal after addition of glucose. This has been used to image the extracellular distribution of glucose in a perfused liver model. Molecular sensors such as these could ultimately prove useful in differentiating between livers producing normal amounts of glucose versus livers overproducing glucose such as in patients with type II diabetes. Note that the SI of CEST 5 SIon-SIoff/SI no Rf. Reproduced from Refs. 46,54. the eight corners of the anticube occupied by the four nitrogen atoms and four carboxylate oxygen atoms of the ligand. (Fig. 4A) . This is not a doubling of r 1 as one might have anticipated because about 50% Table 1 that s m varies by nearly 20-fold for the first six compounds listed, while r 1 changes by less than 20%. However, as one begins to think about targeting one of these small molecule agents to a larger biological structure such as a cell receptor or specific protein for imaging purposes, then s m becomes critically important because the maximum r 1 one can achieve by slowing molecular tumbling depends heavily on the water exchange rate. SBM theory predicts that for a Gd 31 -based T 1 agent to achieve its highest T 1 sensitivity (maximum r 1 ), the optimal bound water lifetime is about 10 ns at 1.5T. 25 As one can see in Table 1 , the bound water lifetime for each of the current clinical agents is too long to achieve optimal r 1 when bound to a biological target. Various strategies to modify s m have been discussed in the literature 60 but we will briefly describe those factors that can be manipulated by basic ligand design. These effects can generally be attributed to stabilization or destabilization of intermediates involved in the water exchange mechanism and/or changes in the population of various CA isomers present in solution.
Strategies to increase the rate of water exchange. Fig. 4B to inspect the ligand structures discussed in this section). While GdDO3A-N-prop displays a near optimal s m value, the kinetic stability of the complex is somewhat compromised compared with GdDOTA. This effect is even more pronounced in GdTRITA, which has a relatively poor kinetic stability (k 1 
). 63 Adding a charged group to the ligand also has an effect on water exchange. For example, addition of an amino group to the propyl sidechain of DO3A-N-prop to yield DO3A-a-amino-prop results in a dramatic shortening of the bound water lifetime (25 ns) in the resulting Gd 31 complex. 64 On the other hand, when a negatively charged acetate group is added to DO3A-N-prop to form DOTA-SA, the water exchange rate in the corresponding Gd 31 complex becomes slower (159 ns) 65 compared to the DO3A-a-amino-prop derivative. An interesting feature of the GdDOTA-SA complex is that its rotational correlation time is slower than GdDOTA (125 ps versus 53 ps, respectively) which must be attributed to the additional negative charge of the extra carboxylate. It is believed that this carboxylate may assemble extra water molecules in the second coordination sphere which makes the effective molecular weight of the complex larger and hence molecular rotation becomes slower. GdDOTA-SA also has the highest thermodynamic stability (log K st 5 27.2) reported to date for DOTA-like complexes and this again can be attributed to the excess negative charge. 65 Addition of a bulky group onto the a position of an acetate sidechain also has an impact on water exchange. For example, when four methyl groups are introduced, one per acetate, as in GdDOTMA, the population of coordination isomers changes from favoring the SAP isomer in GdDOTA to favoring the TSAP isomer in GdDOTMA. Given that water exchange has been observed to be $50-fold faster in TSAP isomers compared with SAP isomers, it is not surprising to find that the measured water exchange lifetime is faster in GdDOTMA (s m 5 85 ns) than in GdDOTA (s m 5 122 ns). cates that the increased steric bulkiness provided by the two methyl substituents can be used to fine-tune water exchange rates in such complexes.
MODULATING THE ROTATIONAL CORRELATION TIME, s R . SBM theory for paramagnetic relaxation predicts that reducing the rate of molecular tumbling (making s R longer) will enhance the relaxivity of a T 1 contrast agent. This fundamental concept has been widely used in the design of biologically responsive agents. s R can be made longer either by coupling the molecular motion of the agent to that of a larger structure such as binding to a protein or by increasing the molecular size of the agent itself. Binding of an agent to a protein is the principle behind gadofosveset trisodium, a low molecular weight complex that binds reversibly to human serum albumin (HSA). In the basic design, the agent is covalently attached through a linker to a unit capable of binding to HSA, thereby slowing molecular reorientation of the agent itself. 68 The nature of the linker and the conformational arrangement of the agent receptor complex determine the efficacy of the construct in slowing molecular motion and thereby enhancing r 1 relaxivity. If the linker is flexible (such as an alkyl chain), then local molecular motion of the agent might dominate s R even with the agent bound at its target. A partial solution to this problem is to use a rigid linker, but even then, the impact on s R will still depend on the conformation attained by the agent when interacting with its macromolecular target. This interaction could in principle increase or decrease the rate of water exchange or perhaps even block water access to the agent entirely. Both scenarios have been observed experimentally. Furthermore, challenges in design are reflected in the behavioral variance that was noted when MS-325 derivatives with different hydration numbers (q 5 0, 1, and 2) (Fig. 4C ) were prepared and characterized in the absence and presence of HSA. 69 In this example, an agent with optimal water exchange properties in aqueous buffer showed a lower than expected increase in r 1 when the agent was bound to the protein target HSA, highlighting the complex interactions of water exchange and/or local motional flexibility.
In a second example, two DOTMA-like derivatives (see BIP-S-NB-3R-DOTMA and BIP-S-NB-3S-DOTMA structures in Fig. 4C ) were modified with a hydrophobic biphenyl unit for binding to HSA. The solution structure of GdBIP-S-NB-3R-DOTMA was locked into the SAP geometry while GdBIP-S-NB-3S-DOTMA was locked into the TSAP geometry. These complexes had bound water lifetimes of 70 71 Gadomer-17 is a good example of such a multimeric system (Fig. 4D) . Gadomer-17 consists of a trimesoyltriamide central core further functionalized with a second-generation lysine dendron having 24 terminal amino residues (a and e). Addition of 24 GdDOTAmonoamide groups to this small dendron yielded a molecule with an MW of 17,500, large enough to be retained in the vascular space somewhat longer than an extracellular agent such as gadopentetate dimeglumine (GdDTPA) or gadoteridol (GdHP-DO3A), and so can be considered a blood pool agent with a distribution similar to that of MS-325. However, unlike MS-325, which has an r 1 of 46.1 mM . Why might this be so? First, the single amide bond in each GdDOTAmonoamide unit of Gadomer-17 has less than optimal water exchange (s M 5 1 ls) and, second, the unrestricted motional flexibility of each appended GdDOTA-monoamide unit limits the agent from "feeling" the impact of being part of a larger molecule. So, even though the rotational correlation time of the dendron backbone structure is reasonably long (3.05 ns), the local rotational correlation time felt by each Gd 31 atom is only about 760 ps. This latter value is about 3.5 times longer than a typical low MW Gd 31 chelate (211 ps for GdDOTA-1-Bz-NO 2 ), but nonetheless not long enough for the agent to experience the full advantages of slow rotation. 72 This combination of factors, a nonoptimal water exchange rate and relatively fast internal rotational motion, combine to limit the relaxivity of the dendron (16.4 mM 21 s
21
, 25 C, 0.47T). Subsequent designs have solved these limitations using various approaches, as illustrated in Fig. 5 . 55, 69, 73 In these designs, the selection of the linker is important not only to give rigidity or mobility to the final construct but also to minimize negative effects on the binding affinity to the receptor.
Current Clinical Examples of the Use of MR Contrast Agents
Eleven intravenously administered MR CAs 74 have been approved for clinical use by the US FDA since gadopentetate dimeglumine (GdDTPA) was first introduced in 1986. The most commonly used in clinical practice are extracellular agents that have no specific tissue biodistribution (an exception is cartilage where the distribution of an anionic agent is lower than a neutral agent because of repulsion from negatively charged glycosoaminoglycans in the tissue) and are quickly eliminated in well-functioning kidneys (t 1/2 $ 1.5 hours). Elimination times increase with renal impairment (t 1/ 2 $ 4-8 hours for moderately impaired subjects and up to 18-34 hours for severely impaired patients). 75 The original application of these agents was to facilitate the detection of central nervous system (CNS) neoplasms (Fig. 6 ). This was followed by other CNS applications such as tumor grading (Fig. 7) and applications geared towards improving the detection and later characterization of tumors throughout the body. 76 Soon after, the first class of organ specific contrast agents emerged with the development of mangafodipir trisodium (Mn-DPDP), Gd-BOPTA, and later Gd-EOB-DTPA as hepatobiliary MRI CAs. 77 The two Gd 31 -based agents are DTPA derivatives containing one lipophilic residue attached to one acetate sidearm. This feature targets each agent to an organic anion transporter in the sinusoidal plasma membrane of the hepatocyte (Fig. 8) . The amount of agent taken up by liver varies considerably, even though the chemistry of the lipophilic groups do not differ substantially ($4% for Gd-BOPTA and 50% for Gd-EOB-DTPA). Both agents have slightly higher relaxivities in vivo compared to GdDTPA due to weak binding interactions with HSA. These slightly higher relaxivities allow these agents to be used at somewhat lower doses which brings potential safety benefits for the patient. 78 A recently approved The metal ion is placed at the barycenter of a molecule designed to limit molecular rotation. One can also increase sensitivity by increasing the number of Gd 31 ions bound at the target site by use of a dendrimer (C) or a straight-chain polymer (D). The relaxivity gains due to restriction rotation can be quite small in (C,D), so other approaches to restrict motion by having multiple points of attachment near the target are illustrated in (E-G). In these illustrations, the black circled 'M's denote ML complexes and the smaller, associated gray circles represent a single water molecule on each chelate.
CA widely, gadofosveset trisodium (Fig. 9 ) binds reversibly to serum albumin (K D 5 85 mM) but has minimal hepatic clearance. Gadofosveset trisodium has a higher affinity for HSA compared to Gd-BOPTA and Gd-EOB-DTPA due to the more lipophilic nature of the biphenylcyclohexyl group. This results in a long plasma lifetime (18.5 hours) and higher relaxivity due to an increase in s R ( Table 1) .
The recognition of NSF as a disease associated with administration of gadolinium chelates has resulted in more awareness of the importance of kinetic stability in choosing the most appropriate CA for clinical use. The incidence of NSF has been shown to be most highly associated with use of the nonionic linear agents gadodiamide and gadoversetamide (GdDTPA-BMA and GdDTPA-BMEA), intermediate with the ionic linear agent gadopentetate dimeglumine (GdDTPA), and lowest with the macrocyclic agents gadoterate meglumine, gadoteridol and gadobutrol (GdDOTA, GdHP-DO3A, and GdDO3A-butrol). In clinical practice, the choice of gadolinium-based contrast agents is a balanced consideration between a given agent's safety, tolerance, efficacy, and cost. As described in this review, the chemical and physical considerations support the use of the macrocyclic agents. This is especially pertinent in those patients with a glomerular filtration rate <30 mL/min. Such individuals are best served when identified before contrast administration either by measuring serum creatinine or by using a questionnaire to identify individuals at risk. 79 The use of macrocyclic agents has expanded worldwide in the last decade and in conjunction with the judicious use of gadolinium protocols in patients with known or suspected renal insufficiency, the incidence of NSF has been substantially reduced.
80,81
Examples of Next-Generation MR Contrast Agents
The first example of a "smart" or "responsive" MRI contrast agent reported in 1997 82 was designed to detect the presence of b-D-galactosidase, an enzyme commonly used in molecular biology as a biomarker of gene expression. This first design was based on an increase water access to the FIGURE 6: Gd-based CA for detection of CNS neoplasm. Sagittal and axial T 2 -weighted (A,B) and T 1 -weighted (C,D) FSE acquisitions with an extensive thoracic syrinx (white arrows) in a patient with progressive neurological deficits. The etiology remains obscure. Postcontrast T 1 -weighted FSE acquisitions in the sagittal (E) and axial (F) planes demonstrate a small avidly enhancing nodule (arrowheads), which was resected and proven to be a hemangioblastoma (benign hypervascular neoplasm). Without the added information from the CA, the syrinx would be considered idiopathic and no treatment options would be available.
inner coordination sphere of the Gd 31 (an increase in q) by removing the blocking group b-D-galactose from one face of a GdDO3A chelate (Fig. 10A) . It was thought that the sugar would at least partially block access of water molecules to the Gd 31 to yield a q 5 0 "off" state and the agent could be turned "on" by cleavage of the sugar unit to allow full access of water ( Unfortunately, very few of these responsive agents have been applied in vivo, so we will limit our discussion here to some of those which have been demonstrated to work in vivo. This will give the reader a sense of potential clinical applications of responsive MRI agents while appreciating their limitations as well. Another responsive contrast agent design for imaging enzyme activity in vivo is exemplified by agents designed to respond to myeloperoxidase (MPO) activity based on slowing molecular rotation. MPO is an important marker of vascular disease in humans since it is highly secreted by neutrophils and macrophages in advanced human FIGURE 7: Value of Gd-based CA for glioma characterization. Axial T 1 -weighted (A) and T 2 -weighted (B) FSE acquisitions demonstrating a large left infiltrative mass consistent with a glial neoplasm, but of uncertain aggressiveness. Postcontrast axial T 1 -weighted FSE acquisition (C) demonstrates a focal region of heterogeneous enhancement (white arrows), a finding usually seen in malignant gliomas. CMV map (D) from T 2 * bolus dynamic susceptibility contrast (DSC) acquisition demonstrates a focal area of markedly increased tumor vascularity (arrowheads) matching the area of enhancement. This area was targeted for stereotactic biopsy, which confirmed the suspicion of an anaplastic glioma.
atherosclerotic plaque. MPO activity in vivo has a clear outcome-predictive value in several cardiovascular diseases, including myocardial infarction and ischemic stroke. 87 MPO-responsive agents take advantage of the known polymerization activity of the enzyme on tyrosine-like derivatives. The basic idea was to functionalize a stable GdDO3A complex with a unit that could be polymerized by MPO, converting it from a low MW, low r 1 agent into a higher MW, higher r 1 polymerized form. Among the first reported MPO-responsive agents was a GdDO3A derivative containing a 5-hydroxytryptamide unit (Fig. 10B) . 88 However, in vivo application of this agent has not been reported, likely due to a modest increase in relaxivity that occurs upon polymerization. This can be attributed to the flexibility of the linker that binds the complex in the polymeric chain. An improved MPO agent was subsequently developed which consists of DTPA derivative having two 5-hydroxytryptamide units (Fig. 10B) , which should in principle promote cross-linking of the polymer matrix to increase the rigidity of the paramagnetic complex 89 and thereby yield a greater increase in r 1 relaxivity. The utility of this GdDTPA-bis-5-hydroxytryptamide to image MPO activity in vivo was demonstrated by imaging mice 2 days after coronary ligation before and after intravenous injection of GdDTPA-bis-5-hydroxytryptamide (or GdDTPA as control) at 0.3 mmol/kg dose. Mice injected with the MPOresponsive agent showed sustained contrast enhancement in the injured myocardium at 120 minutes after injection while image contrast in control mice returned to baseline after 60 minutes. The prolonged enhancement of the MPOresponsive agent was attributed to cross-linking of the agent to surrounding matrix proteins. 90 Responsive MRI agents have also been designed to target specific proteins known to be overexpressed in certain pathologies. Among the first examples of these include fibrin and collagen. Thrombosis or blood clot formation is the underlying pathology in myocardial infarction, ischemic stroke, pulmonary embolism, and deep vein thrombosis, FIGURE 8: Use of Gd-EOB-DTPA for characterization of focal nodular hyperplasia. Fat-suppressed 3D T 1 -weighted images obtained during the arterial phase (A) and at 20 minutes (B) after the intravenous administration of 0.025 mmol/kg gadoxetic acid. Note the high signal intensity of the focal mass in the left lobe of the liver (arrow) on the arterial phase with sustained enhancement of the lesion on the delayed phase, the latter including substantial diffuse background liver enhancement. FIGURE 9: Clinical application of the blood pool properties of gadofosveset trisodium during follow-up of a patient with an aortic aneurysm. Contrast-enhanced CT scan (A) was of limited diagnostic value due to prominent streak artifacts from metal. GdMS-325 contrast-enhanced MRA during a blood pool phase acquisition demonstrates excellent signal intensity on the inferior vena cava (V) as well as in the arterial prosthesis (arrowheads). The white arrow demonstrates an endoleak, which was not detected on CT.
conditions that affect millions of individuals worldwide. In the clotting process, activated platelets and fibrin form a hemostatic plug. Fibrin is formed when the enzyme thrombin cleaves the fibrin peptides on circulating fibrinogen protein enabling end-to-end polymerization of the fibrinogen moieties. The resultant fibrin mesh is further stabilized with cross-linking induced by the enzyme, Factor XIII. Fibrin is an excellent target for MR detection since it is present in arterial and venous clots at high concentrations (20-100 lM) but is not found in plasma. One of the most promising fibrin-responsive agents is EP-2104R, a cyclic peptide with four appended GdDOTA complexes (Fig. 11A) 1.5T, 37 C, pH 7.4) when bound to fibrin. This enhanced relaxivity can be attributed largely to slowing of molecular rotational motion when the complex is bound to largely immobile fibrin clot. EP-2104R is effective at providing positive contrast enhancement in preclinical models of carotid artery, coronary artery, atrial and cerebral venous sinus, thrombosis, and pulmonary embolism. 91 Due to its success in preclinical tests, EP-2104R was the first responsive contrast agent to advance to clinical trials. A similar approach has been used to create a collagen I-specific MRI contrast agent, which could be applied for screening of chronic diseases of the heart, kidney, liver, lungs, or vasculature (Fig. 11B) 
SUMMARY
MR CAs continue to play an important role in the arsenal of tools available to the clinical radiologist. Although many of the CAs introduced over the past 27 years have similar features in terms of r 1 relaxivity and size, some are ionic while others are nonionic, some have appended organic groups which increase the relative uptake in liver, but most distribute quickly into all extracellular space. Gadofosveset trisodium is unique among them in that it was designed to have a modest affinity for serum albumin so that it would remain in the vascular space for an extended period of time.
Newer agents that respond to some specific biological function hold great promise for improving diagnostic content in medical imaging. However, the current regulatory environment challenges the successful and timely implementation of new agents into clinical practice. Meanwhile, scientists around the world have been busy unraveling the fundamental physical and chemical limitations of current CAs and developing new designs capable of providing much more specific biological information. Many groups have demonstrated that the rate of water exchange on-and-off a CA is the key physical parameter for the successful development of new agents having the highest sensitivity for detection by MRI. Given the recent exciting advances in biologically responsive Gd 31 -based T 1 agents and Eu
31
-based paraC-EST agents, it is our hope that many new agents will become part of the arsenal of available tools for clinical practice in the coming years. 21 and insulin in these mice. The mouse on the right was fed a high-fat diet for 12 weeks to expand b-cell mass. The expanded colored areas in this image reflect a larger functional pancreas (increased b-cell function) in this animal. This process is known to occur in diet-induced obesity (DIO) mouse models. 94 Functional agents such as this may one day allow imaging of b-cell function in humans during development of type II diabetes or as a biomarker to test new drugs designed to improve b-cell function.
GLOSSARY
Coordination Sphere: refers to a central atom or ion and array of molecules or anions (the ligands) around. The first coordination sphere refers to the molecules that are attached directly to the atom of interest. Molecules that are attached noncovalently to the ligands are called the second coordination sphere.
Dendrimer/Dendron: The term "dendrimer" is derived from the Greek words dendron, meaning tree and meros, meaning part. Dendrimers are repetitively branched molecules, a type of chemical polymer, with sizes and physicochemical properties resembling those of biomolecules, eg, proteins. Applications include the conjugation of other chemical species to the dendrimer surface that can function as detecting agents.
Diamagnetism: A common property of materials with even numbers of electrons orbiting in atoms that makes a weak contribution to the material's response in a magnetic field. For those materials that possess other forms of magnetism (such as ferromagnetism or paramagnetism), the diamagnetic contribution becomes negligible. Substances that mostly display diamagnetic behavior are termed diamagnetic materials, or diamagnets.
Hydration Number: refers to the number of water molecules that a metal ion can combine/coordinate in aqueous solution.
Isomers: Molecules with the same molecular formula but different chemical structures.
Line Broadening: In proton NMR spectroscopy, a proton signal appears along a range frequencies, according to how a given proton is influenced by its local environment, often referred to as signal "peaks". This is most commonly thought of as the magnetic properties of a proton being influenced by the electron clouds from the associated bonds with other atoms. In the simplest construct each signal or peak would be a sharp straight line at the relevant frequency (blue and red lines), but in reality, the signals have a certain width, due to a variety of factors that influence this signal (blue dashed line). Those factors induce a widening to the signal or peak spread the frequency distribution over a slightly broader range (double headed dashed arrow), a phenomenon known as line broadening. This also results in a decrease in the amplitude (lower signal).
Macrocyclic: refers to a cyclic macromolecule or a macromolecular cyclic portion of a molecule. Molecules containing a ring of seven or more atoms are usually considered to be a macrocycle.
Monomer: A molecule which can undergo polymerization thereby contributing constitutional units to the essential structure of a macromolecule.
Multimeric System A structure composed of several identical or different subunits held together by weak bonds.
Paramagnetism: a common property of materials with odd numbers of electrons orbiting in atoms. Paramagnetic materials have a small, positive susceptibility to magnetic fields. These materials are slightly attracted by a magnetic field and the material does not retain the magnetic properties when the external field is removed (in contrast to ferromagnetic materials that do retain magnetic properties).
Rotational Correlation Time: corresponds to the time it takes for a molecule to rotate one radian, and depends mainly on particle size.
Superparamagnetism: refers to a special magnetic property that occurs commonly in small nanoparticles, which display ferromagnetic properties. Superparamagnetic materials, in the presence of an external magnetic field, tend to align their ferromagnetic domains generating a strong magnetic interaction.
Peptoid: class of peptidomimetic (small protein-like chain designed to mimic a peptide) whose side chains are appended to the nitrogen atom of the peptide backbone, rather than to the a-carbons (as they are in amino acids). They are completely resistant to proteolysis and therefore advantageous for therapeutic applications where proteolysis is a major issue.
Polyamino-Based Ligand: compounds containing one or more nitrogen atoms connected through carbon atoms (amines).
Residence Time: average amount of time that a water molecule spends coordinated in the inner-sphere of the metal complex system. Also known as mean lifetime.
Steric Hindrance: the prevention or retardation of inter-or intra-molecular interactions as a result of the spatial structure of a molecule.
Swift-Connick Equations: approximations used to estimate rate parameters for elementary reactions, primary used for NMR in aqueous solutions.
Transchelation: type of chemical reaction in which one chelate group replaces another in solution.
Transmetallation: type of chemical reaction in which one ion metal replaces another in solution.
